| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/23/2006 | CN1823044A Mixtures of ionic liquids with lewis acids |
| 08/23/2006 | CN1823043A Hydroxypyridine cgrp receptor antagonists |
| 08/23/2006 | CN1821243A Substituted pyridine M receptor excitomotor, its preparing process and its use |
| 08/23/2006 | CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/23/2006 | CN1271066C Aromatic dicarboxylic acid derivatives |
| 08/23/2006 | CN1271055C Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
| 08/23/2006 | CN1270713C Synergistic pharmaceutical combination for prevention or treatment of diabetes |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 08/22/2006 | US7094906 Processes for preparing pesticidal intermediates |
| 08/22/2006 | US7094896 Diaminothiazoles having antiproliferative activity |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094794 used for lowering the blood glucose and for the prevention and treatment of diabetes |
| 08/22/2006 | CA2399834C Preparation of dialkylpyridylboranes |
| 08/22/2006 | CA2257825C New processes for preparing pesticidal intermediates |
| 08/17/2006 | WO2006086602A2 Improved process for the preparation of 3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine |
| 08/17/2006 | WO2006085199A1 Piperazine derivatives |
| 08/17/2006 | WO2006084688A1 HIV protease inhibitors |
| 08/17/2006 | WO2006084369A1 Diamine calcium channel blockers |
| 08/17/2006 | WO2006037982A3 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | US20060183918 Beta 2-adrenergic receptor agonists |
| 08/17/2006 | US20060183908 Heterocyclic compounds, methods of making them and their use in therapy |
| 08/17/2006 | US20060183791 Substituted p-diaminobenzene derivatives |
| 08/17/2006 | US20060183783 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 08/17/2006 | US20060183754 Amide bridged piphenyl or biazaphenyl derivatives |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | US20060182992 Organic electroluminescent devices and metal complex compounds |
| 08/17/2006 | CA2597393A1 Improved process for the preparation of 3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine |
| 08/17/2006 | CA2597087A1 Diamine calcium channel blockers |
| 08/17/2006 | CA2594395A1 Hiv protease inhibitors |
| 08/16/2006 | EP1690854A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 08/16/2006 | EP1690853A1 W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/16/2006 | EP1690847A1 pi-Conjugated compound having cardo structure, process for the preparation thereof and use thereof |
| 08/16/2006 | EP1690824A1 Mobile work platform |
| 08/16/2006 | EP1689716A1 Biaryl sulfonamides and methods for using same |
| 08/16/2006 | EP1689715A1 Tubulin inhibitors |
| 08/16/2006 | EP1689714A2 Therapeutic use of pyridinium compounds to modulate naadp activity |
| 08/16/2006 | EP1689713A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease |
| 08/16/2006 | EP1689706A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders |
| 08/16/2006 | EP1689704A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 08/16/2006 | EP1689698A1 Bis-cationic compounds and use thereof |
| 08/16/2006 | EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689403A2 Heteroaryl-hydrazone compounds |
| 08/16/2006 | EP1689394A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689380A2 Method for treating adamts-5-associated disease |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1087941B1 Thiolesters and uses thereof |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1820000A A method for the preparation of enantiomerically pure mirtazapine |
| 08/16/2006 | CN1817884A Pyrimidinone derivatives and 3-keto ester |
| 08/16/2006 | CN1817862A Production of pyriphenanthrenone as anti-fibrosis medicine |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/16/2006 | CN1269802C A short synthesis of pyridine-based pharmaceutical intermediates with salfur-containing groups at the 2-and 3-positions |
| 08/16/2006 | CN1269801C Amino acid derivatives and drug containing the same as the active ingredient |
| 08/16/2006 | CN1269800C Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091245 Peroxisome proliferator activator; antidiabetic agents; insulin resistance; |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091224 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
| 08/15/2006 | US7091210 Substituted 2-aminoacetamides and the use thereof |
| 08/15/2006 | US7090931 Photoactive layer containing a lanthanide complex, in particular, lanthanide2(beta-enolate)6(pyridine-N-oxide)3; electronic devices in which the active layer includes a photoactive lanthanide complex |
| 08/15/2006 | US7090756 Controller for redox system |
| 08/15/2006 | CA2256309C Amidino protease inhibitors |
| 08/10/2006 | WO2006084031A1 Imines as ion channel modulators |
| 08/10/2006 | WO2006083930A2 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 08/10/2006 | WO2006083673A2 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082834A1 Agent for prevention/therapy of disease caused by keratinocyte growth |
| 08/10/2006 | WO2006082768A1 Ionic organic compound |
| 08/10/2006 | WO2006082495A1 Peroxisome proliferator activated receptor modulators |
| 08/10/2006 | WO2006081759A1 N-(2-substituted phenyl)-n-methoxycarbamates and their preparation as well as use |
| 08/10/2006 | WO2006044602A3 Diphenyl substituted alkanes as flap inhiibitors |
| 08/10/2006 | US20060178517 (DHP), by heating a mixture of butyraldehyde, aniline, and acetic acid to a first temperature, holding at said temperature, then heating to a second higher temperature and holding; controlling the rate of reaction and temperature of the reaction |
| 08/10/2006 | US20060178513 Pyridinylanilides |
| 08/10/2006 | US20060178438 Muscarinic agonists |
| 08/10/2006 | US20060178429 2-Phenyl-3-hydrogenated furanyl, pyranyl, thiophenyl or thiopyranyl-N-heteroaromatic propionamides, e.g., 2-(3,4-Dichloro-phenyl)-3-(tetrahydro-pyran-2-yl)-N-thiazol-2-yl-propionamide; compounds increase insulin secretion in the treatment of type II diabetes. |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178409 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060177621 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 08/10/2006 | US20060175604 Novel type of attachment of organic molecules to a silicon surface for producing memory elements having organic constituents |
| 08/10/2006 | CA2594505A1 Imines as ion channel modulators |
| 08/10/2006 | CA2593550A1 Compounds for inflammation and immune-related uses |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688138A1 Receptor function regulating agent |
| 08/09/2006 | EP1687307A2 Substituted imidazo ring systems and methods |
| 08/09/2006 | EP1687298A1 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| 08/09/2006 | EP1687288A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 08/09/2006 | EP1687284A2 p-38 KINASE INHIBITORS |